Your browser doesn't support javascript.
loading
Survival of chemo-naïve patients with EGFR mutation-positive advanced non-small cell lung cancer after treatment with afatinib and bevacizumab: updates from the Okayama Lung Cancer Study Group Trial 1404.
Ninomiya, Takashi; Nogami, Naoyuki; Kozuki, Toshiyuki; Harada, Daijiro; Kubo, Toshio; Ohashi, Kadoaki; Ichihara, Eiki; Kuyama, Shoichi; Kudo, Kenichiro; Bessho, Akihiro; Sakugawa, Makoto; Fujimoto, Nobukazu; Aoe, Keisuke; Minami, Daisuke; Sugimoto, Keisuke; Ochi, Nobuaki; Takigawa, Nagio; Hotta, Katsuyuki; Maeda, Yoshinobu; Kiura, Katsuyuki.
Afiliação
  • Ninomiya T; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
  • Nogami N; Department of Thoracic Oncology and Medicine, National Hospital Organization, Shikoku Cancer Center, Matsuyama, Japan.
  • Kozuki T; Department of Community Medicine, Pulmonology and Cardiology, Ehime University Graduate School of Medicine, Toon, Japan.
  • Harada D; Department of Thoracic Oncology and Medicine, National Hospital Organization, Shikoku Cancer Center, Matsuyama, Japan.
  • Kubo T; Department of Thoracic Oncology and Medicine, National Hospital Organization, Shikoku Cancer Center, Matsuyama, Japan.
  • Ohashi K; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
  • Ichihara E; Center for Clinical Oncology, Okayama University Hospital, Okayama, Japan.
  • Kuyama S; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
  • Kudo K; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Okayama, Japan.
  • Bessho A; Department of Respiratory Medicine, Iwakuni Clinical Center, Iwakuni, Japan.
  • Sakugawa M; Department of Respiratory Medicine, Iwakuni Clinical Center, Iwakuni, Japan.
  • Fujimoto N; Department of Respiratory Medicine, Japanese Red Cross Okayama Hospital, Okayama, Japan.
  • Aoe K; Department of Respiratory Medicine, Japanese Red Cross Okayama Hospital, Okayama, Japan.
  • Minami D; Department of Medical Oncology, Okayama Rosai Hospital, Okayama, Japan.
  • Sugimoto K; Department of Medical Oncology, National Hospital Organization, Yamaguchi-Ube Medical Center, Ube, Japan.
  • Ochi N; Department of Respiratory Medicine, National Hospital Organization, Okayama Medical Center, Okayama, Japan.
  • Takigawa N; Department of Respiratory Medicine, Japanese Red Cross Kobe Hospital, Kobe, Japan.
  • Hotta K; Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan.
  • Maeda Y; Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan.
  • Kiura K; Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
Jpn J Clin Oncol ; 51(8): 1269-1276, 2021 Aug 01.
Article em En | MEDLINE | ID: mdl-34115855
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 3_ND Problema de saúde: 3_diarrhea Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Mutação Limite: Humans Idioma: En Revista: Jpn J Clin Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 3_ND Problema de saúde: 3_diarrhea Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Mutação Limite: Humans Idioma: En Revista: Jpn J Clin Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão